Shams Elham, Bonnice Sabrina, Mayrovitz Harvey N
Osteopathic Medicine, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Davie, USA.
Medical Education, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Davie, USA.
Cureus. 2022 Jan 18;14(1):e21369. doi: 10.7759/cureus.21369. eCollection 2022 Jan.
Fluid retention is common in patients with heart failure (HF) and diuretics are a major source of management and stabilization. Diuretic resistance (DR) is defined as a failure to achieve therapeutically desired congestion relief despite using an appropriate diuretic dose. In this study, the underlying mechanisms of DR in HF patients are described and several currently available evidence-based strategies to mitigate this condition are provided. Specific aims were to investigate how DR occurs in patients with HF, how HF medications interfere with diuretic treatment, and what alternative methods are available for patients with DR while undergoing treatment for HF. Results provide several rationales for novel strategies used to help reach a state of euvolemia where there is a proper amount of blood in the circulatory system. These include reducing sodium intake, changing the timing of drug administration, and modifying diuretic dose.
液体潴留在心力衰竭(HF)患者中很常见,利尿剂是管理和稳定病情的主要手段。利尿剂抵抗(DR)的定义是,尽管使用了适当的利尿剂剂量,但仍未能实现治疗所需的充血缓解。在本研究中,描述了HF患者DR的潜在机制,并提供了几种目前可用的基于证据的减轻这种情况的策略。具体目标是研究HF患者中DR是如何发生的,HF药物如何干扰利尿剂治疗,以及在HF治疗期间DR患者有哪些替代方法。结果为用于帮助达到血容量正常状态(即循环系统中有适量血液)的新策略提供了几个理论依据。这些策略包括减少钠摄入、改变给药时间和调整利尿剂剂量。